Middle East Molecular Modelling Market, by End User
| Label | Pharmaceutical & Biotechnology Companies | Research & Academic Centers | Others |
|---|---|---|---|
| 2017 | 11.1 USD Mn | 8.05 USD Mn | 23.55 USD Mn |
| 2018 | 12.22 USD Mn | 8.9 USD Mn | 25.75 USD Mn |
| 2019 | 13.54 USD Mn | 9.92 USD Mn | 28.36 USD Mn |
| 2020 | 15.05 USD Mn | 11.08 USD Mn | 31.31 USD Mn |
| 2021 | 16.71 USD Mn | 12.37 USD Mn | 34.54 USD Mn |
| 2022 | 18.55 USD Mn | 13.8 USD Mn | 38.11 USD Mn |
| 2023 | 20.54 USD Mn | 15.36 USD Mn | 41.92 USD Mn |
| 2024 | 22.71 USD Mn | 17.06 USD Mn | 46.05 USD Mn |
| 2025 | 25.02 USD Mn | 18.89 USD Mn | 50.4 USD Mn |
| 2026 | 27.45 USD Mn | 20.83 USD Mn | 54.93 USD Mn |
| 2027 | 29.98 USD Mn | 22.86 USD Mn | 59.6 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Middle East Molecular Modelling Market, by End User, 2017 market is on a steady long-term growth path. Segment value stands at roughly USD 103 Mn in 2026 and is projected to reach USD 112 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
- Of the 3 groups compared here, Others is out front by 2027 at 59. 60M USD — 53% of the group total.
- What the regional split looks like (2026): Others leads, holding roughly 53% of segment value — the single largest regional share. Pharmaceutical & Biotechnology Companies is the second-largest contributor. Research & Academic Centers make up the remainder, in descending order.
- By 2027, Others alone is expected to reach USD 60 Mn, with Pharmaceutical & Biotechnology Companies at USD 30 Mn.
Market Dynamics
Of the 3 groups compared here, Others is out front by 2027 at 59.60M USD — 53% of the group total.
Next is Pharmaceutical & Biotechnology Companies, at 29.98M USD — 50% behind Others.
Others: up 153% over the period, 23.55M USD to 59.60M USD.
Pharmaceutical & Biotechnology Companies: 11.10M USD to 29.98M USD, 170% higher by 2027.
Research & Academic Centers grows to 22.86M USD by 2027, from 8.05M USD in 2017 — 184% up.
By rate of change, not size, Research & Academic Centers is the standout — 184% growth, faster than the rest of the group.
The 3-group total: 42.70M USD in 2017, 112.44M USD by 2027, 163% overall.
Reading A Multi-Series Chart
There are 3 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.
Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.
The most practical way to read this is relative: set the Middle East Molecular Modelling market figures beside other regions or segments of the same market to see where growth is concentrated.
This is a market research forecast, not an official statistic. Values after the 2018 base year are modeled projections to 2027, based on supply-side and demand-side analysis, and are updated when market conditions change.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllMiddle East Molecular Modelling Market, by Industry Sector
Middle East Molecular Modelling Market, by Application
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



